The Serum Institute of India will make 90 million doses of AstraZeneca in June from about 65 million a month now, a company spokesman told Reuters. Bharat Biotech also plans to ramp up production of its Covaxin vaccine to 23 million in June from about 10 million in April, a government official said.
